Displaying 911-920 of 935 results for

Put the paper and pencil away. Hybrid data management and analysis systems-where users combine paper tracking with computer processing-are no longer meeting the needs of manufacturers for speed, accuracy, traceability and compliance with regulations.

As I walked the floor this spring at North America’s largest trade show for automation technologies, Industry 4.0 was on everybody’s lips. One of the more complex of our industrial revolutions, Industry 4.0 has been about the Internet of Things: digitizing and connecting things.

With an influx of investment in digital factories, the playing field is changing and the ROI for digitizing production is becoming ever more apparent. However, restraints, such as company size and a disconnect between IT and OT, means the road to a successful digital transformation is one very few will be able to do alone.

For years, companies have struggled to understand how additive manufacturing (AM) can add value to their businesses. This makes sense because for a long time, additive tech didn’t meet the threshold for producing industrial-grade parts.

Well into the 21st century, the medical industry faces a host of intriguing challenges, from aging populations to a growing range of personalized and at-home diagnostic and care devices—all set against a backdrop of increasing digital collection, transfer and storage of sensitive patient data.

Speeding the flow of jobs through the shop, while maintaining top quality, ranks among the hallmarks of any successful manufacturing operation’s goals.

Hexagon Manufacturing Intelligence, a business unit of Hexagon AB, outlined its vision for the future of manufacturing at HxGN Live, the company’s annual digital solutions conference, held June 11-15 in Las Vegas.

Blockchain technology is becoming a key player in modernizing supply chains to enable easy tracking, automate transactions and delivery, and build end-to-end trust, Chandra Narayanaswami, principal research staff member, Member IBM Academy of Technology at IBM Research, told people attending a smart manufacturing session at the MD&M West conference here last week.

The requirements for FDA 21 CFR Part 11 are in place for a good reason: When companies are making a part that goes inside your body, the engineering and manufacturing process must be meticulously documented, tested and controlled. People’s lives are at stake.

The human factor is sometimes just too cumbersome in manufacturing. Take the German chipmaker Infineon: By using an autonomous robot called Scout from MetraLabs for the last several years, the automotive supplier shrank to 10 from 300 the number of minutes it takes to collect the clean-room data needed to measure the presence of rare gases in the air.